L302-0931 Screening compound: 3,3-dimethyl-1-(2-methylpropanoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide

L302-0931 Screening compound: 3,3-dimethyl-1-(2-methylpropanoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide
L302-0931 Screening compound: 3,3-dimethyl-1-(2-methylpropanoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L302-0931
3,3-dimethyl-1-(2-methylpropanoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L302-0931

Molecular Formula

C24H30N2O3S (C24 H30 N2 O3 S)

Compound Name

3,3-dimethyl-1-(2-methylpropanoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

33-dimethyl-1-(2-methylpropanoyl)-N-(1234-tetrahydronaphthalen-1-yl)-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(C)C(N(CC1(C)C)c(cc2)c1cc2S(NC(CCC1)c2c1cccc2)(=O)=O)=O

InChI

InChI=1S/C24H30N2O3S/c1-16(2)23(27)26-15-24(3,4)20-14-18(12-13-22(20)26)30(28,29)25-21-11-7-9-17-8-5-6-10-19(17)21/h5-6,8,10,12-14,16,21,25H,7,9,11,15H2,1-4H3/t21-/m0/s1

InChI Key

KUZNTHYTHGIMSJ-NRFANRHFSA-N

MDL Number (MFCD)

MFCD27242834

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.347

Distribution Coefficient, logD

5.347

Water Solubility, LogSw

-5.24

Polar Surface Area

57.938

Acid Dissociation Constant (pKa)

10.27

Base Dissociation Constant (pKb)

-3.44

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.80

L302-0931 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Others
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L302-0931 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L302-0931?
Check Price and Availability of L302-0931, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L302-0931 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L302-0931
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L302-0931
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L302-0931 available by request